BioCorRx (BICX) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
BioCorRx (BICX) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | 1.75% |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 72.91% |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 18.44% |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 3,280.00% |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 25.06% |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 10.11% |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 104.67% |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | -7.60% |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 184.24% |
| 10 | BioCorRx | - | - | 189,355.00 | -0.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.95% |
| Dec 31, 2025 | -185.59% |
| Sep 30, 2025 | 46.38% |
| Jun 30, 2025 | -11.61% |
| Mar 31, 2025 | 31.17% |
| Dec 31, 2024 | -26.69% |
| Sep 30, 2024 | -74.44% |
| Jun 30, 2024 | -33.61% |
| Mar 31, 2024 | -22.45% |
| Dec 31, 2023 | 16.45% |
| Sep 30, 2023 | 8.80% |
| Jun 30, 2023 | 29.83% |
| Mar 31, 2023 | -7.00% |
| Dec 31, 2022 | 8.62% |
| Sep 30, 2022 | 30.22% |
| Jun 30, 2022 | -24.01% |
| Mar 31, 2022 | 40.38% |
| Dec 31, 2021 | -40.29% |
| Sep 30, 2021 | -73.57% |
| Jun 30, 2021 | -43.70% |